Recent News and Updates
Ultragenyx Wilson Disease Gene Therapy Trial Update for WDA
As requested, we are providing an update on Stage 1 of our Cyprus2+ study, assessing safety and efficacy of UX701, an investigational gene therapy for the treatment of Wilson disease. The status update below [...]
Vivet Therapeutics’ Wilson Disease Gene Therapy Clinical Trial Update
On behalf of the Vivet Therapeutics Wilson disease study team, we are happy to share updates about the ongoing and enrolling GATEWAY clinical trial.GATEWAY is an international gene therapy clinical trial for people living with [...]
Wilson Disease Reviewed in Top Medical Journal
The Wilson Disease Association (WDA) is excited to share that the review article, “Current and Emerging Issues in Wilson’s Disease,” by Dr. Eve Roberts and Dr. Michael Schilsky is published in this week’s New [...]
Ultragenyx Wilson Disease Update August 2023
On behalf of the Ultragenyx Wilson disease study team, we would like to share an update on our CYPRUS2+ study. […]
How Mark Cuban helped a Cherry Hill business exec cut prices for the drug that keeps him alive
For decades, the drug that keeps Drew Katz alive sold for less than $1 a pill. […]
WD Low Cost Drugs
Read the press release.